Pathologist onsite cuts repeat thyroid biopsies
Having a pathologist onsite during ultrasound-guided thyroid biopsies can decrease the number of repeat biopsies performed due to an inadequate sample, according to a study presented at the American Roentgen Ray Society annual meeting.
Having a pathologist onsite during ultrasound-guided thyroid biopsies can decrease the number of repeat biopsies performed due to an inadequate sample, according to a study presented at the American Roentgen Ray Society annual meeting.
University of North Carolina researchers compared 200 biopsies performed with a pathologist onsite and 200 with no pathologist present. All other factors being equal, 13.5% of biopsies performed without a pathologist onsite needed to be repeated, compared with only 5% where a pathologist was onsite, according to the research.
An inadequate sample is one where the pathologist deems there is an insufficient amount of tissue to make a diagnosis.
“We recommend that radiologists performing large numbers of thyroid biopsies use onsite pathology as it may reduce the need for repeat biopsy by up to 60%,” said Dr. Wui K. Chong, lead author of the study and an associate professor of radiology at UNC.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
